DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Ferdinand KC, Botros FT, Atisso CM. et al.
Cardiovascular safety for once‑weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
Cardiovasc Diabetol 2016;
15: 38-50
We do not assume any responsibility for the contents of the web pages of other providers.